← SynDRA
LINTITRIPT
SynDRA canonical compound SYN0007880 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CCKAR |
|---|
| Mechanism of action | CCK receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- CCK receptor antagonist
- CCKAR ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- NTHL1
- HTR1B
- HTR1D
- HTR1E
- HTR2B
- HTR2C
- HTR5A
- KAT2A
- MBD4
- MPG
- MUTYH
- NEIL1
- NEIL2
- OGG1
- ADRA1B
- OPRD1
- OPRK1
- OPRM1
- S1PR1
- SIGMAR1
- SLC6A3
- SMUG1
- TDG
- TMEM97
- TSPO
- UNG
- USP1
- HTR1A
- HRH4
- HRH3
- HRH1
- ADRA1D
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- APLNR
Cross-references
Synonyms
- SR-27897
- SR-27897B
- SR27897
- 1-((2-(4-(2-Chlorophenyl)thiazol-2-yl)aminocarbonyl)indolyl)acetic acid
- 2-((4-(o-Chlorophenyl)-2-thiazolyl)carbamoyl)indole-1-acetic acid
- 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]acetic acid
- 3YFV00531K
- DTXCID7026738
- SR 27897B
- lintitriptum
- RefChem:799304
- Lintitript [INN]
- NCGC00167729-01
- C20H14ClN3O3S
- CAS-136381-85-6
- UNII-3YFV00531K
- SCHEMBL27123
- GTPL890
- SR 27897 (Lintitript)
- orb1308124
- SCHEMBL29375302
- BDBM82304
- CHEBI:92624
- GLXC-25021
- HMS3268P15
- HMS3413K13
- HMS3677K13
- HMS3742K11
- LFA38185
- Tox21_112581
- EX-A14833
- MFCD21608519
- PDSP1_000946
- PDSP2_000932
- AKOS024456979
- Tox21_112581_1
- CAS_122077
- CCG-221891
- NSC_122077
Look up LINTITRIPT in the interactive SynDRA portal →